Can You Use an HSA for Weight Loss Injections? Rules and Penalties

You can use an HSA for weight loss injections when a doctor prescribes them to treat a diagnosed medical condition — obesity, type 2 diabetes, or an overweight diagnosis paired with something like hypertension or sleep apnea. The same shot taken purely to slim down, with no underlying diagnosis, is a personal expense and doesn’t qualify. That line matters, because spending HSA money on a non-qualified expense costs you income tax on the withdrawal plus a 20 percent penalty.

Which Diagnoses Make the Injection Qualify

IRS Publication 502 treats weight-loss expenses as qualified medical care when the treatment targets a specific disease diagnosed by a physician, such as obesity, hypertension, or heart disease.1Internal Revenue Service. Publication 502 – Medical and Dental Expenses The IRS settled the underlying question in Revenue Ruling 2002-19, which held that obesity itself is a disease and treating it is medical care.2Internal Revenue Service. Revenue Ruling 2002-19

In practice, the diagnoses that support HSA use for Wegovy, Zepbound, or a similar injection are:

  • Obesity, generally a BMI of 30 or higher
  • Overweight (BMI of 27 or higher) with a comorbidity such as hypertension, high cholesterol, sleep apnea, or type 2 diabetes
  • Type 2 diabetes, where the medication is prescribed to manage blood sugar

Without a diagnosis on the chart, the expense is cosmetic or wellness spending in the IRS’s eyes, and it doesn’t qualify.

Wegovy, Zepbound, and Ozempic

The FDA approval on the label affects how cleanly a claim goes through, even though the HSA test is really about the diagnosis.

Wegovy (semaglutide) is approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition.3U.S. Food and Drug Administration. Wegovy Prescribing Information Zepbound (tirzepatide) carries the same indication at those BMI thresholds.4U.S. Food and Drug Administration. Zepbound Prescribing Information When either is prescribed for a qualifying diagnosis, the link between medication and condition is easy to document.

Ozempic contains the same active ingredient as Wegovy but is approved only for type 2 diabetes. Doctors often prescribe it off-label for weight loss. The IRS does not prohibit off-label prescriptions from qualifying, since the test is whether the expense treats a diagnosed disease, but administrators tend to ask more questions when the label and the diagnosis don’t line up. Documentation has to be tight.

The Letter of Medical Necessity

HSA administrators typically want a Letter of Medical Necessity before they approve a weight loss injection claim. This is a short letter from your prescribing doctor that ties the medication to a specific diagnosis. A useful letter names:

  • The diagnosis being treated, such as obesity with a stated BMI, type 2 diabetes, or hypertension
  • The prescribed drug, dosage, and how it’s administered
  • The medical reason this drug is necessary rather than merely helpful for general health
  • The expected duration of treatment

Most administrators treat the letter as valid for about 12 months and want a renewal if treatment continues. That renewal cycle is an administrator convention, not an IRS rule, so check the exact requirement with your HSA provider. Getting the letter before your first purchase is far easier than producing one after a claim is flagged. A brief office or telehealth visit is usually enough.

How to Pay With Your HSA

The simplest way is to swipe your HSA debit card at the pharmacy. Prescription medications are usually coded automatically, and the transaction clears without extra paperwork.

If you pay out of pocket first, you can submit a reimbursement claim through your HSA administrator’s portal. You’ll usually need to upload the itemized pharmacy receipt showing the drug name and amount, together with your Letter of Medical Necessity. There is no deadline for reimbursing yourself, as long as the HSA was open when the expense was incurred, so some people pay out of pocket on purpose and let the HSA balance keep growing tax-free before reimbursing later.

What These Drugs Cost Against Your HSA Balance

At retail, Wegovy runs roughly $1,350 to $1,640 per month and Zepbound is around $1,271 per month before insurance or manufacturer discounts. A full year at retail can easily exceed $15,000.

For 2026, the IRS set HSA contribution limits at $4,400 for self-only coverage and $8,750 for family coverage, with an extra $1,000 catch-up contribution if you’re 55 or older.5Internal Revenue Service. Revenue Procedure 2025-19 Retail cost for a year of Wegovy can be three to four times the self-only annual contribution. Accumulated balances from prior years help; otherwise the practical answer is combining HSA funds with insurance coverage or manufacturer discount programs. HSA money can only pay for the portion of a cost that insurance hasn’t already reimbursed.6Office of the Law Revision Counsel. 26 U.S. Code 223 – Health Savings Accounts

Continuing the Injection After You Reach Your Goal Weight

GLP-1 medications are often prescribed indefinitely because weight tends to return after stopping. The tax code defines medical care to include mitigation and prevention of disease, not just active treatment of current symptoms.7Office of the Law Revision Counsel. 26 U.S. Code 213 – Medical, Dental, Etc., Expenses If your doctor determines continued medication is necessary to prevent recurrence of obesity or to manage an ongoing condition like type 2 diabetes, the expense should remain qualified. The IRS FAQ on medical expenses ties eligibility to whether the expense alleviates or prevents a physical or mental disability or illness.8Internal Revenue Service. Frequently Asked Questions About Medical Expenses Related to Nutrition, Wellness and General Health Updating the Letter of Medical Necessity each year, with your doctor stating that continued treatment is medically necessary, protects you if the expense is later questioned.

Penalties if the Expense Doesn’t Qualify

If HSA funds pay for an expense that doesn’t qualify, the IRS treats the distribution as taxable income and adds a 20 percent penalty tax.9Internal Revenue Service. Publication 969 – Health Savings Accounts and Other Tax-Favored Health Plans On a $1,400 monthly injection, that’s roughly $280 in penalty plus income tax on the full amount, and it applies to every non-qualified distribution.

Two exceptions to the 20 percent penalty: it disappears once you turn 65, and it doesn’t apply if you become disabled. Non-qualified distributions in either case are still added to your taxable income, but the extra penalty falls off.9Internal Revenue Service. Publication 969 – Health Savings Accounts and Other Tax-Favored Health Plans For anyone under 65, the penalty is steep enough that squaring away documentation before you spend is worth the small effort.

Records You Need to Keep

The IRS can ask for proof that HSA distributions were spent on qualified expenses, and that request can arrive years later. Keep records for at least three years from the date you filed the return covering the distribution.10Internal Revenue Service. How Long Should I Keep Records Longer is smarter if you ever plan to reimburse yourself for an older expense.

For each injection purchase, save the itemized pharmacy receipt showing drug name, date, and cost, along with your current Letter of Medical Necessity. A digital folder organized by year is enough. Thermal-paper pharmacy receipts fade within months, so scan or photograph them soon after pickup. A faded receipt is effectively no receipt if the IRS asks.

A Note on Compounded Semaglutide and Tirzepatide

Compounded versions of these drugs follow the same HSA rule as brand-name versions: Publication 502 allows the cost of any drug that requires a physician’s prescription.1Internal Revenue Service. Publication 502 – Medical and Dental Expenses The harder issue is availability. The FDA’s enforcement discretion periods for compounded semaglutide and tirzepatide have ended now that the national shortage has resolved. As of April 2026, the FDA has indicated it won’t pursue compounders filling four or fewer prescriptions per calendar month, but may still act on quality or safety violations.11U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize If you use a compounded version, confirm the pharmacy is properly licensed and your prescription is current before you worry about the HSA side.